v3.26.1
Commitments and Contingencies (Tables)
 3 Months Ended
Mar. 31, 2026
Commitments and Contingencies [Abstract]  
Schedule of Future Milestones A payment schedule for future milestones is summarized below.
Milestone Bearing Event  Milestone
Payment		 
1.  License Fee to utilize proprietary technology (paid)   $300,000 + $2.4 million Convertible Note 
2.  Commencement of a toxicology study commented pursuant to Good Laboratory Practices (per 21 CFR Part 58) such that any resulting positive data would be admissible to applicable Regulatory Authorities to support an IND (commonly referred to as “GLP-Tox”)  $375,000 
3.  Completion of a Phase I Clinical Trial  $1,500,000 
4.  Completion of a Phase II Clinical Trial  $2,500,000 
5.  Filing of an NDA, BLA or MAA registration (or the equivalent in any other territory around the world)  $6,000,000 
6.  Regulatory Approval in the first of the United States, within the EU or within the UK  $12,000,000 
Schedule of Certain Fees and Corresponding Payment Amounts The fee schedule for certain fees and corresponding payment amounts is set forth below.
George Clinical Payment Schedule   Payment
Amount		  
1.   Service Fee Advance (paid)   $ 49,989  
2.   Service Fee Advance of $212,335 minus the amount already paid, plus PTC Fee Advance of $31,325 (paid)   $ 193,671  
3.   Statistics Fees – 35% on Electronic Data Capture (EDC) Go Live Date   $ 47,740  
4.   Statistics Fees – 35% on Development of SAP tables   $ 47,740  
5.   Statistics Fees – 30% on Final Analysis   $ 40,920  
6.   Service Fees – Remainder Due     Split monthly over course of study